Eric K Rowinsky Insider Trading
Get free email notifications about insider trading for Eric K Rowinsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eric K Rowinsky. Eric K Rowinsky is a Chief Medical Officer in IMCLONE SYSTEMS INC ($IMCLE) and a SVP, CHIEF MEDICAL OFFICER in IMCLONE SYSTEMS INC ($IMCLE) and a Director in BIOGEN INC. ($IDPH) and a Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a Chief Medical Officer in STEMLINE THERAPEUTICS INC ($STML) and a Director in BIND Therapeutics, Inc ($BIND) and a Director in Fortress Biotech, Inc. ($FBIO) and a Director in Verastem, Inc. ($VSTM).
Address: IMCLONE SYSTEMS INCORPORATED 33 IMCLONE DRIVE BRANCHBURG 08876 NJ
Companies in which Eric K Rowinsky is an Insider
BIOGEN INC.
Trading Symbol: IDPHIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Eric K Rowinsky: Director
Holdings: 17,069 shares
Latest Transaction: Jun 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DNIB UNWIND, INC.
Trading Symbol: BINDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eric K Rowinsky: Director
Holdings: 15,000 shares
Latest Transaction: Aug 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Fortress Biotech, Inc.
Trading Symbol: FBIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eric K Rowinsky: Director
Holdings: 750,000 shares
Current Value: $1,920,000
Latest Transaction: Apr 09 2021
$FBIO Market Capitalization: $124.63M
$FBIO Previous Close: $2.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMCLONE SYSTEMS INC
Trading Symbol: IMCLEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Eric K Rowinsky: SVP, CHIEF MEDICAL OFFICER, Chief Medical Officer
Holdings: 1,774 shares
Latest Transaction: Feb 20 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NAVIDEA BIOPHARMACEUTICALS, INC.
Trading Symbol: NAVBIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Eric K Rowinsky: Director
Holdings: 341,446 shares
Current Value: $177,552
Latest Transaction: Feb 22 2018
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
STEMLINE THERAPEUTICS INC
Trading Symbol: STMLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eric K Rowinsky: Chief Medical Officer
Holdings: 143,688 shares
Current Value: $890,866
Latest Transaction: Apr 28 2015
$STML Market Capitalization: $118.68M
$STML Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verastem, Inc.
Trading Symbol: VSTMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eric K Rowinsky: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 18 2020
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Eric K Rowinsky
Sentiment: All, IDPH, BIND, FBIO, IMCLE, NAVB, STML, VSTM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.45 | 10,000 | 44,500 | 720,000 | 730 K to 720 K (-1.37 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.31 | 8,000 | 34,480 | 730,000 | 738 K to 730 K (-1.08 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.20 | 6,000 | 25,200 | 738,000 | 744 K to 738 K (-0.81 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 3.86 | 2,000 | 7,720 | 744,000 | 746 K to 744 K (-0.27 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 3.80 | 4,000 | 15,200 | 746,000 | 750 K to 746 K (-0.53 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 750,000 | 650 K to 750 K (+15.38 %) |
Jun 18 2020 | VSTM | Verastem, Inc. | Rowinsky Eric K | Director | Option Exercise | A | 1.77 | 25,000 | 44,250 | 25,000 |